More and more cancer patients are surviving the disease but suffer with debilitating pain as a result of chemotherapy treatment, particularly in the feet and hands. The nerve damage can affect the patient’s ability to walk and use their hands. But an NBC News affiliate broadcast this new report on October 11 about a new clinical study by the University of Wisconsin which determined Calmare’s MC-5A scrambler therapy is the first known therapy to show measurable results in helping to alleviate CIPN pain. “This technology has consistently shown very impressive results in our blind study, ” reports Toby Campbell, MD, chief of Palliative Medicine, University of Wisconsin.
As a result, a larger more extensive study has been approved. For anyone interested in participating in the study at the University of Wisconsin-Madison, call 800-622-8922.
Dr. Michael J. Cooney
Rutherford Allied Medical Group
November 11, 2011 at 10:44 am
We will be welcoming our first patient from Europe who is coming here to NJ for Calmare Therapy to alleviate her chronic pain as a result of chemotherapy treatment. Medication has not proven to alleviate the pain.
October 26, 2011 at 9:23 am
This adds to the legitimacy of what you are trying to do. Looks very positive. I have read the study (I am a PT).
October 18, 2011 at 4:04 pm
We couldn’t agree more Mr. Williams. We will see you in NJ soon!
Safe travels.
October 14, 2011 at 5:51 pm
To far away! bummer! Id be the perfect subject,Dont smoke,drink&non diabetic! Im going to N.J. to get same treatment! Its my only hope! come on insurance,Whats the problem?